Last reviewed · How we verify
NCT06311877
Effects of Flavor Modification for Management of Radiation Induced Dysgeusia
NA trial testing mBerry in Dysgeusia in 30 participants. Enrolling by invitation.
14 December 2026
Quick facts
| Lead sponsor | University of South Florida |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 8 September 2024 |
| Primary completion | 14 December 2026 |
| Estimated completion | 14 April 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- mBerry
- No intervention
Conditions studied
- Dysgeusia — all drugs for Dysgeusia →
Sponsor
University of South Florida
Who can join
Adults 18 to 90, any sex, with Dysgeusia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intervention for dysgeusia in head and neck cancer patients undergoing radiation therapy. This research proposal aims to investigate potential benefits of mBerry in improving quality of life and nutritional outcome in head and neck cancer patients' post-radiation therapy. Our hypothesis is that cancer patients undergoing radiation therapy will benefit from use of miracle berry in treatment of dysgeusia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06311877
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dysgeusia
Currently open trials in the same condition.
- NCT04791436 — Oral and Olfactory Complications of Recovered COVID-19 Patients · recruiting
- NCT02304913 — Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy · NA · recruiting
Other University of South Florida trials
Trials by the same sponsor.
- NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
- NCT07342569 — The WeACT Program for Family Caregivers of People Living With Dementia · NA · not yet recruiting
- NCT07502378 — Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic · Phase 4 · recruiting
- NCT07241260 — Hydrate Heroes for Improving Brain Function & Mood · NA · not yet recruiting
- NCT06377215 — Understanding Aided Speech Perception in Noise · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06311877 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Florida
- Last refreshed: 18 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06311877.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing